How does systemic exposure to icatibant acetate in people aged 75–80 years differ from that in people aged 40 years?

Data suggest systemic exposure to icatibant acetate is approximately 50–60% higher in people aged 75–80 years than in those aged 40 years because of an age-related decline in clearance.